Annette Mary Griffin

Title: Annette Mary Griffin: Innovator in Viral Nucleotide Sequences

Introduction

Annette Mary Griffin is a distinguished inventor based in Huntingdon, GB. She has made significant contributions to the field of virology, particularly in the identification and manipulation of viral nucleotide sequences. With a total of 5 patents to her name, her work has implications for vaccine development and genetic research.

Latest Patents

Her latest patents focus on various genes of the herpes virus of turkeys (HVT), Marek's disease virus (MDV), and infectious laryngotracheitis virus (ILTV). These patents identify non-essential regions that serve as candidates for insertion sites for foreign genes and/or as antigen-encoding regions. The identified regions include the HVT homologue of the HSV gC gene, the thymidine kinase region of MDV or ILTV, and several other critical genes. The manipulation of these genes allows for the preparation of vaccines that comprise attenuated viruses or viruses carrying heterologous antigen-encoding sequences.

Career Highlights

Throughout her career, Annette has worked with notable companies such as Merial Limited and Rhone Merieux S.A. Her expertise in virology and genetic engineering has positioned her as a key figure in the development of innovative vaccine technologies.

Collaborations

She has collaborated with esteemed colleagues, including Simon David Scott and Matthew M Binns, contributing to advancements in her field.

Conclusion

Annette Mary Griffin's work in viral nucleotide sequences has paved the way for significant advancements in vaccine development. Her contributions continue to impact the field of virology and public health.